Cargando…

Analysis of Updates in Multiple Myeloma Treatment and Management

INTRODUCTION: During the past two decades, new therapeutic agents have greatly improved the treatment landscape in multiple myeloma (MM). Treatments such as proteasome inhibitors, immunomodulatory agents, targeted monoclonal antibody therapy, and chimeric antigen receptor (CAR) T-cell therapy have i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nieto, Maria Jacqueline, Hedjar, Aryles, Locke, Margaret, Caro, Jessica, Saif, Muhammad Wasif
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673627/ https://www.ncbi.nlm.nih.gov/pubmed/38009096 http://dx.doi.org/10.33696/haematology.4.055

Ejemplares similares

Pain Management in Patients with Multiple Myeloma: An Update
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

2016 Gastrointestinal Cancers Symposium: update on pancreatic cancer
por: Russo, Suzanne, et al.
Publicado: (2016)

Selecting treatment options in refractory metastatic colorectal cancer
por: Byrne, Margaret, et al.
Publicado: (2019)

Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update
por: Abramson, Hanley N.
Publicado: (2018)

Update on the optimal use of bortezomib in the treatment of multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2017)

Lower 24-Month Relative Survival among Black Patients with Non- Hodgkin’s Lymphoma: An Analysis of the SEER Data 1997–2015
por: Nieto, Maria J, et al.
Publicado: (2021)

Management of a Patient with Metastatic Colorectal Cancer and Liver Metastases
por: Saif, Muhammad Wasif
Publicado: (2014)

Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide
por: Schoenbeck, Kelly L, et al.
Publicado: (2020)

Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity
por: Saif, Muhammad Wasif
Publicado: (2020)

Diagnosis and management of multiple myeloma during pregnancy: case report, review of the literature, and an update on current treatments
por: Magen, Hila, et al.
Publicado: (2022)

Managing multiple myeloma
por: Lee, Ann S., et al.
Publicado: (2021)

Treatment options for refractory/relapsed multiple myeloma: an updated evidence synthesis by network meta-analysis
por: Luo, Xian-Wu, et al.
Publicado: (2018)

Comprehensive Updates in the Role of Imaging for Multiple Myeloma Management Based on Recent International Guidelines
por: Lee, Koeun, et al.
Publicado: (2021)

Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
por: Li, Jia, et al.
Publicado: (2009)

Epidemiology of multiple myeloma in 17 Latin American countries: an update
por: Curado, Maria Paula, et al.
Publicado: (2018)

Recent progress in the treatment of multiple myeloma: updates and highlights from ASH 2008
por: Jagannath, Sundar
Publicado: (2009)

Update on elotuzumab for the treatment of relapsed/refractory multiple myeloma: patients’ selection and perspective
por: Trudel, Sabrina, et al.
Publicado: (2019)

Recent updates on CAR T clinical trials for multiple myeloma
por: Lin, Quande, et al.
Publicado: (2019)

Managing treatment-related peripheral neuropathy in patients with multiple myeloma
por: Grammatico, Sara, et al.
Publicado: (2016)

Multiple Myeloma (Part 1) – Update on Epidemiology, Diagnostic Criteria, Systemic Treatment and Prognosis
por: Guedes, Alex, et al.
Publicado: (2023)

Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009)

Multiple myeloma: an overview of management
por: Bird, Sarah Anne, et al.
Publicado: (2019)

Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-Analyses
por: Georgakopoulou, Rebecca, et al.
Publicado: (2021)

Multiple Myeloma (Part 2) - Update on The Approach to Bone Disease
por: Guedes, Alex, et al.
Publicado: (2023)

Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review
por: Nishida, Hiroko
Publicado: (2021)

CD38-Directed Therapies for Management of Multiple Myeloma
por: Hashmi, Hamza, et al.
Publicado: (2021)

Management of oxaliplatin-induced peripheral neuropathy
por: Saif, M Wasif, et al.
Publicado: (2005)

Role and Cost Effectiveness of PET/CT in Management of Patients with Cancer
por: Saif, Muhammad Wasif, et al.
Publicado: (2010)

Genetic factors affecting patient responses to pancreatic cancer treatment
por: Fotopoulos, George, et al.
Publicado: (2016)

Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis
por: Derman, Benjamin A., et al.
Publicado: (2020)

Targeting cancers in the gastrointestinal tract: role of capecitabine
por: Saif, Muhammad Wasif
Publicado: (2009)

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer
por: Saif, Muhammad Wasif
Publicado: (2012)

Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?
por: Saif, Muhammad Wasif
Publicado: (2013)

Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: an updated meta-analysis
por: Donato, Francesca, et al.
Publicado: (2020)

Management of cardiovascular risk in patients with multiple myeloma
por: Plummer, Chris, et al.
Publicado: (2019)

Bispecific antibody treatment of multiple myeloma: latest updates from the 2022 ASH annual meeting
por: Yin, Xuejiao, et al.
Publicado: (2023)

Imatinib-induced Ototoxicity in a Patient with Gastrointestinal Stromal Tumor (GIST)
por: Wasif, Komal, et al.
Publicado: (2016)

Bupropion-Induced Acute Dystonia with Dose Escalation and Use of Naranjo Nomogram
por: Wasif, Nawal, et al.
Publicado: (2017)

Managing anemia in lymphoma and multiple myeloma
por: Birgegård, Gunnar
Publicado: (2008)

Epidemiology, Staging, and Management of Multiple Myeloma
por: Padala, Sandeep Anand, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uii847dasnd7bq378i0daukffn